SLC6A3 and Parkinson disease: Imaging of presynaptic neurons using positron emission tomography (PET) or single photon emission computed tomography (SPECT) with a radioligand for dopamine transporters (DATs) cannot distinguish between PD and MSA, especially on the individual level, because both diseases cause neuronal degeneration in the substantia nigra (SN) [1, 2].